The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients

The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients

Abstract Background Recent randomized trials have not found that polymyxin B hemoperfusion (PMX-HP) improves outcomes for patients with sepsis. However, it remains unclear whether the therapy could provide benefit for highly selected patients. Monocyte human leukocyte antigen (mHLA-DR) expression, a...

Full description

Bibliographic Details
Main Authors: Nattachai Srisawat, Somkanya Tungsanga, Nuttha Lumlertgul, Chalermchai Komaenthammasophon, Sadudee Peerapornratana, Nicha Thamrongsat, Khajohn Tiranathanagul, Kearkiat Praditpornsilpa, Somchai Eiam-Ong, Kriang Tungsanga, John A. Kellum
Format: Article
Language:English
Published: BMC 2018-10-01
Series:Critical Care
Subjects:
Immunoparalysis
Severe sepsis/septic shock
Polymyxin B hemoperfusion
Online Access:http://link.springer.com/article/10.1186/s13054-018-2077-y

Internet

http://link.springer.com/article/10.1186/s13054-018-2077-y

Similar Items